Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 609-066-0 | CAS number: 35123-06-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
An efficient absorption rate can be assumed after oral or dermal exposure. The absorption after inhalation is limited by the low vapour pressure and the solubility in mucus, which facilitates the removal from upper respiratory tracts. Once absorbed, the substance is expected to be effectively metabolized (liver as primary site of metabolism). As major metabolite, lactic acid is formed, which is further processed like dietary lactic acid. A second major metabolite is propanamide, 2-hydroxy-N-monomethyl, which is expected to be effectively excreted via the urine. This excretion pathway could also be undergone by the parental substance as such, due to high water solubility and small size. A bioaccumulation is considered unlikely.
Key value for chemical safety assessment
Additional information
1. Chemical and physico-chemical description
Generally, the substance propanamide, 2-hydroxy-N,N-dimethyl- (CAS 35123-06-9) belongs to the compound class of N,N-dimethylamides. It contains furthermore a lactic acid side chain with a free hydroxy group.
No experimental data on absorption, metabolism and distribution are available for the substance as such. In literature, the toxicokinetic behavior of a variety of N,N-dimethylamides is described (Wiles & Narcisse, 1971; Irwin et al., 1990). Further implications for the toxicokinetic assessment can be derived from the physic-chemical properties of propanamide, 2-hydroxy-N,N-dimethyl-.Description of the physico-chemical properties:
- physical state: liquid
- vapour pressure:1.2*10-4 atm ( <= 12 Pa;<=0,12 mbar) at 20 °C
- molecular weight: appr. 116 Da
- logPow: -0.94
- water solubility: >5000 g/L
- Boiling point: 224 °C (at 1031 mbar)
2. Toxicokinetic assessment
2.1 Absorption:
In the gastro-intestinal tract, passive diffusion of propanamide, 2-hydroxy-N,N-dimethyl- is likely because of the low molecular weight (appr. 116 Da), the moderate log Pow (-0.94) and the high water solubility. An uptake via aqueous pores or through the epithelial barrier by the bulk passage of water is possible.
In spite of the relatively small molecular size, the substance to be registered has a low vapour pressure of 1.2*10-4 atm ( <= 12 Pa;<=0,12 mbar; at 20 °C) and a relatively high boiling point (224 °C at 1031 mbar), indicating that inhalation as a vapour will be limited. Because of the high water solubility, the substance is likely to dissolve in the mucus of the upper respiratory tract, and is thus expected to be removed effectively. If the substance reaches the respiratory tract, passive diffusion across the respiratory tract epithelium is favorable because of the low molecular weight (appr. 116 Da), the moderate log Pow (-0.94) and the high water solubility.
In the publication of Irwin et al., several N,N-dimethylamides were investigated for their potential to enhance the percutaneous absorption of ibuprofen and naproxen through rat skin. Among the tested N,N-dimethylamides themselves, those with a C10 alkyl chain penetrated most effectively (Kp = 9.26 – 10.05 x 103cm h-1). Smaller molecules had a lower penetration rate (e.g. N,N-dimethylhexanamide: Kp = 1.63 x 103cm h-1). As modeled with DERMWIN (v.1.43), a Kp of 3 x 103cm h-1can be assumed for propanamide, 2-hydroxy-N,N-dimethyl-, which points to a good dermal uptake. The results of Irwin et al. furthermore showed that the dermal barrier was not destroyed due to the application of N,N-dimethylamides.
In the study of Wiles and Narcisse, the acute toxicity after intragastric, percutaneous, intravenous or intraperitoneal aministration was evaluated with a variety of 12 N,N-dimethylamides. The authors observed that deaths occurred later after dermal exposure (15-20 hours after application) compared to parenteral administration (2-6 hours). The results confirm that N,N-dimethylamides are well absorbed by the skin, though not as effective as via the oral route.
2.2 Metabolism:
Once absorbed, a rapid distribution and metabolization of propanamide, 2-hydroxy-N,N-dimethyl- is expected, which takes primarily place in the liver. A stepwise demethylation is considered to be the major pathway. The product of the first demethylation step is propanamide, 2-hydroxy-N-monomethyl. This molecule can be further metabolized to lactic acid (2-hydroxypropanoic acid) via a second demethylation step. Lactic acid is also a dietary ingredient and/or formed during physiological processes; therefore efficient metabolic mechanisms are in place. Just like dietary lactic acid, the lactic acid formed in the degradation of of propanamide, 2-hydroxy-N,N-dimethyl- is reduced to lactate by the enzyme lactate dehydrogenase. The lactate is then either oxidized to pyruvate, which enters the Krebs cycle, or is converted to glucose via the gluconeogenesis process.
2.3 Excretion
The metabolite propanamide, 2-hydroxy-N monomethyl is expected to be excreted via urine. Because of the small size of the molecule and the high water solubility, the parent compound propanamide, 2-hydroxy-N,N-dimethyl- could leave the body unchanged by biliary excretion as well. Because of the high water solubility and the expected efficient metabolism and excretion, an accumulation of propanamide, 2-hydroxy-N,N-dimethyl- is unlikely.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)